Join us tonight at 7pm in Rocky 209 to hear from Associate Professor of Medicine at Dartmouth Medical School and an adjunct Associate professor at Tuck School Dr. Conway!! Below is his bio




Don Conway has recently been appointed Director for Health Care Initiatives at Dartmouth . In this position he will lead collaborative efforts of the Dartmouth Medical School , The Center for the Clinical Evaluative Sciences and Tuck Business School . These efforts will be focused on addressing issues confronting the Health Care Industry.


Prior to his appointment, Dr. Conway was Head of Global Health Economics and Research of Outcomes (HERO) for Aventis Pharma. In this position, his primary role was to develop analyses of practice patterns, practice guidelines, cost-effectiveness and Quality of Life Studies. These efforts were focused on demonstrating the true value argument for Aventis products. Through an understanding the cost offsets (fewer hospitalization, shorter length of stay, fewer after visits and more rapid return to work or usual activities), the true value of medical therapies is best appreciated. Dr .Conway participated in clinical trials by helping to define the appropriate patient population and key indications, which best demonstrated the benefits of treatments. Also, he directed QoL research by advising on appropriate and validated survey instruments, to document the impact these new treatments had on patient lives. His group then performed the requisite analyses to ensure that data are included in the economic dossiers required by government, and regulatory authorities for pricing and reimbursement .


Prior to joining Aventis Pharma, Dr. Conway was Global Director of Epidemiology and Heath Outcomes Research for Abbott Laboratories. In 1989, Dr. Conway established the Dept. of Technology Management for the American Medical Association, which was American Medicine's first dedicated venture in Health Technology Assessment. His duties for the AMA also included developing Health Policy and he has represented medicine's interest before US Congress and the FDA. Dr. Conway has served as chairman of the multinational, industry wide Global Health Policy Group. He has actively participated in Managed Care Advisory Boards covering both product related and Quality of Care issues and has conducted Quality Improvement studies in managed care, and academic medical center settings (Massachusetts General Hospital).


In 2002, Dr. Conway was voted onto PhRma's Health Outcomes Committee which formulates health policies and practices . Dr. Conway received his Doctor of Medicine (MD) and training from Rush Medical College in Chicago, holds an MBA from the Amos Tuck School of Business at Dartmouth College.


Dr. Conway is an Associate Professor of Medicine at Dartmouth Medical School and an adjunct Associate professor at Tuck School. Dr. Conway has published in peer-reviewed journals American Medical Association (JAMA),and The Annals of Internal Medicine.